Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry

Eye

Volumn 24, Issue 7, 2010, Pages 1252-1258

  Quaranta, L ^a   Konstas, A G P ^b   Rossetti, L ^c   Garcia Feijoo, J ^d   O'Brien, C ^e   Nasr, M B ^b   Fogagnolo, P ^f   Demos, C M ^g   Stewart, J A ^h   Stewart, W C ^h  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Glaucoma Unit   (Greece)

^c UNIVERSITY OF MILAN   (Italy)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^f IRCCS FONDAZIONE BIETTI   (Italy)

^g Charleston Research Company LLC   (United States)

^h University of South Carolina   (United States)

Author keywords

24 h intraocular pressures; Goldmann tonometry; nighttime supine intraocular pressures; Perkins tonometry

Indexed keywords

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; SELF EXAMINATION; SITTING; SUPINE POSITION; TONOMETRY;

EID: 77954751093     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.300     Document Type: Article

References (42)

1. Kida T, Liu JH, Weinreb RN. Effect of 24-h corneal biomechanical changes on intraocular pressure measurement. Invest Ophthalmol Vis Sci 2006; 47: 4422-4426.
2. Liu JH, Kripke DF, Twa MD, Hoffman RE, Mansberger SL, Rex KM et al. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci 1999; 40: 2912-2917.
3. Weinreb RN, Liu JH. Nocturnal rhythms of intraocular pressure. Arch Ophthalmol 2006; 124: 269-270.
4. Quaranta L, Gandolfo F, Turano R, Rovida F, Pizzolante T, Musig A et al. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma. Invest Ophthalmol Vis Sci 2006; 47: 2917-2923.
5. Konstas AG, Nakos E, Tersis I, Lallos NA, Leech JN, Stewart WC. A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol. Am J Ophthalmol 2002; 133: 753-757.
6. García-Feijoo J, Martínez-de-la-Casa JM, Castillo A, Méndez C, Fernández-Vidal A, García-Sánchez J. Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%. Curr Med Res Opin 2006; 22: 1689-1697.
7. Konstas AG, Mikropoulos D, Haidich AB, Ntampos KS, Stewart WC. 24-h intraocular pressure control with the travoprost/timolol fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma. Br J Ophthalmol 2009; 93: 481-485.
8. Konstas AG, Tsironi S, Vakalis AN, Nasr MB, Stewart JA, Nelson LA et al. Intraocular pressure control over 24 h using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma. Acta Ophthalmol Scan 2009; 87: 71-76.
9. Konstas AG, Mikropoulos D, Kaltsos K, Jenkins JN, Stewart WC. 24-h intraocular pressure control obtained with evening versus morning dosed travoprost in primary openangle glaucoma. Ophthalmology 2006; 113: 446-450.
10. Barkana Y, Anis S, Liebmann J, Tello C, Ritch R. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol 2006; 124: 793-797.
11. Orzalesi N, Rossetti L, Bottoli A, Fogagnolo P. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Ophthalmology 2006; 113: 239-246.
12. Hughes E, Spry P, Diamond J. 24-h monitoring of intraocular pressure in glaucoma management: a retrospective review. J Glaucoma 2003; 12: 232-236.
13. Wilensky JT. The role of diurnal pressure measurements in the management of open angle glaucoma. Curr Opin Ophthalmol 2004; 15: 90-92.
14. Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 2000; 41: 2566-2573.
15. Fogagnolo P, Rossetti L, Mazzolani F, Orzalesi N. Circadian variations in central corneal thickness and intraocular pressure in patients with glaucoma. Br J Ophthalmol 2006; 90: 24-28.
16. Rossetti L, Karabatsas CH, Topouzis F, Vetrugno M, Centofanti M, Boehm A et al. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure. Ophthalmology 2007; 114: 2244-2251.
17. Tajunisah I, Reddy SC, Fathilah J. Diurnal variation of intraocular pressure in suspected glaucoma patients and their outcome. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1851-1857.
18. Liu JH, Bouligny RP, Kripke DF, Weinreb RN. Nocturnal elevation of intraocular pressure is detectable in the sitting position. Invest Ophthalmol Vis Sci 2003; 44: 4439-4442.
19. Liu JH, Kripke DF, Weinreb RN. Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure. Am J Ophthalmol 2004; 138: 389-395.
20. Lagerlöf O. Airpuff tonometry versus applanation tonometry. Acta Ophthalmol (Copenh) 1990; 68: 221-224.
21. Stewart WC. Clinical Practice of Glaucoma. SLACK, Inc.: Thorofare, 1990, pp 255-297.
22. Ritch R. The Glaucomas. Mosby-Year Book, Inc.: St Louis, 1996, pp 1426-1430.
23. Stewart WC, Holmes KT, Johnson MA. Washout periods for brimonidine 0.2% and latanoprost 0.005%. Am J Ophthalmol 2001; 131: 798-799.
24. Stroman GA, Stewart WC, Stewart JA, Deitz TM. Safety of beta-adrenergic blocker washout period in clinical trials. Acta Ophthalmol Scand 1997; 75: 94-95.
25. Schlecht LP, Brubaker RF. The effects of withdrawal of timolol in chronically treated glaucoma patients. Ophthalmology 1988; 95: 1212-1216.
26. Baskett JS, Goen TM, Terry JE. A comparison of Perkins and Goldmann applanation tonometry. J Am Optom Assoc 1986; 57: 832-834.
27. Krieglstein GK, Waller WK. Goldmann applanation versus hand-applanation and schiötz indentation tonometry. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1975; 194: 11-16.
28. Chiara GF, Semes LP, Potter JW, Cutter GR, Tucker WR. Portable tonometers: a clinical comparison of applanation and indentation devices. J Am Optom Assoc 1989; 60: 105-110.
29. Wingert TA, Bassi CJ, McAlister WH, Galanis JC. Clinical evaluation of five portable tonometers. J Am Optom Assoc 1995; 66: 670-674.
30. Wozniak K, Köller AU, Spörl E, Böhm AG, Pillunat LE. Intraocular pressure measurement during the day and night for glaucoma patients and normal controls using Goldmann and Perkins applanation tonometry. Ophthalmologe 2006; 103: 1027-1031.
31. Duff GR. A double-masked crossover study comparing the effects of carteolol 1 and 2% on intraocular pressure. Acta Ophthalmol (Copenh) 1987; 65: 618-621.
32. Mundorf TK, Cate EA, Sine CS, Otero DW, Stewart JA, Stewart WC. The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily. J Ocul Pharmacol Ther 1998; 14: 129-135.
33. Book SA. Essentials of Statistics. McGraw-Hill, Inc.: New York, 1978, pp 205-215.
34. Kiuchi T, Motoyama Y, Oshika T. Relationship of progression of visual field damage to postural changes in intraocular pressure in patients with normal-tension glaucoma. Ophthalmology 2006; 113: 2150-2155.
35. Liu JH, Kripke DF, Hoffman RE, Twa MD, Loving RT, Rex KM et al. Nocturnal elevation of intraocular pressure in young adults. Invest Ophthalmol Vis Sci 1998; 39: 2707-2712.
36. Stewart WC, Konstas AGP, Nelson LA, Kruft B. Metaanalysis of 24-h intraocular pressure studies evaluating the efficacy of glaucoma medicines. Ophthalmology 2008; 115: 1117-1122.
37. Stewart WC, Kolker AE, Sharpe ED, Day DG, Konstas AG, Hollo G et al. Long-term progression at individual mean intraocular pressure levels in primary open-angle and exfoliative glaucoma. Eur J Ophthalmol 2008; 18: 765-770.
38. Ocular Hypertension Treatment Study Group and the European Glaucoma Prevention Study Group. The accuracy and clinical application of predictive models for primary open-angle glaucoma in ocular hypertensive individuals. Ophthalmology 2008; 115: 2030-2036.
39. Heijl A, Bengtsson B, Chauhan BC, Lieberman MF, Cunliffe I, Hyman L et al. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients. Ophthalmology 2008; 115: 1557-1565.
40. Spry PG, Bates AB, Johnson CA, Chauhan BC. Simulation of longitudinal threshold visual field data. Invest Ophthalmol Vis Sci 2000; 41: 2192-2200.
41. Jonas JB, Budde W, Stroux A, Oberacher-Velten IM, Jünemann A. Single intraocular pressure measurements and diurnal intraocular pressure profiles. Am J Ophthalmol 2005; 139: 1136-1137.
42. Prata Jr JA, Mérmoud A, LaBree L, Minckler DS. In vitro and in vivo flow characteristics of glaucoma drainage implants. Ophthalmology 1995; 102: 894-904.